Unknown

Dataset Information

Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.


ABSTRACT:

Background

Minocycline is a clinically available synthetic tetracycline derivative with anti-inflammatory and antibiotic properties. The majority of studies show that minocycline can reduce tissue damage and improve functional recovery following central nervous system injuries, mainly attributed to the drug's direct anti-inflammatory, anti-oxidative, and neuroprotective properties. Surprisingly the consequences of minocycline's antibiotic (i.e., antibacterial) effects on the gut microbiota and systemic immune response after spinal cord injury have largely been ignored despite their links to changes in mental health and immune suppression.

Methods

Here, we sought to determine minocycline's effect on spinal cord injury-induced changes in the microbiota-immune axis using a cerv

SUBMITTER: Schmidt EKA 

PROVIDER: S-EPMC8234629 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature